162 related articles for article (PubMed ID: 318226)
1. In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria.
Sutter VL; Kirby B; Finegold SM
Rev Infect Dis; 1979; 1(1):218-23. PubMed ID: 318226
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity and synergism of cefuroxime on anaerobic bacteria.
Thadepalli H; White DW; Bach VT
Chemotherapy; 1981; 27(4):252-8. PubMed ID: 7249787
[TBL] [Abstract][Full Text] [Related]
3. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
Barry AL; Jones RN; Thornsberry C
Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092
[TBL] [Abstract][Full Text] [Related]
4. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
Thabaut A; Durosoir JL; Saliou P
Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
[TBL] [Abstract][Full Text] [Related]
5. Comparative in-vitro activity of ceftazidime (GR-20263) and other beta-lactamase stable cephalosporins against anaerobic bacteria.
Chow AW; Bartlett KH
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():91-5. PubMed ID: 19802974
[TBL] [Abstract][Full Text] [Related]
6. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
Harper PB
Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
[TBL] [Abstract][Full Text] [Related]
7. Comparison between agar and broth minimum inhibitory concentrations of cefamandole, Cefoxitin, and cefuroxime.
Rylander M; Brorson JE; Johnsson J; Norrby R
Antimicrob Agents Chemother; 1979 Apr; 15(4):572-9. PubMed ID: 464588
[TBL] [Abstract][Full Text] [Related]
8. Anaerobic bacteria: evaluation of disc susceptibility to four cephalosporins.
Dubois J; Pechère JC
Infection; 1978; 6(6):266-70. PubMed ID: 730395
[TBL] [Abstract][Full Text] [Related]
9. Lack of in vitro activity of cefoxitin, cefamandole, cefuroxime, and piperacillin against Chlamydia trachomatis.
Bowie WR
Antimicrob Agents Chemother; 1982 Feb; 21(2):339-40. PubMed ID: 6462108
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
Miller MA; Yousuf M; Griffin PS; Bartlett M; Crane JK
Microbiol Immunol; 1979; 23(10):955-64. PubMed ID: 390321
[TBL] [Abstract][Full Text] [Related]
11. [3 new cephalosporins: cefamandole, cefuroxime, cefoxitin].
Mirimanoff RO; Héraïef E
Rev Med Suisse Romande; 1981 Dec; 101(12):963-8. PubMed ID: 7342276
[No Abstract] [Full Text] [Related]
12. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins].
Braveny I; Dickert H; Machka K
Infection; 1979; 7(5):231-6. PubMed ID: 389804
[TBL] [Abstract][Full Text] [Related]
13. Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin.
Brorson JE; Norrby R
Scand J Infect Dis Suppl; 1978; (13):88-93. PubMed ID: 278150
[No Abstract] [Full Text] [Related]
14. Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
Thabaut A; Durosoir JL; Saliou P
Chemotherapy; 1981; 27 Suppl 1():19-24. PubMed ID: 6265159
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of first, second and third generation cephalosporins.
Forsgren A
Acta Pathol Microbiol Scand B; 1981 Aug; 89(4):221-5. PubMed ID: 6274143
[TBL] [Abstract][Full Text] [Related]
16. Comparative antimicrobial activity of aminothiazolyl methoxyimino cephalosporins against anaerobic bacteria, including 100 cefoxitin-resistant isolates.
Jones RN; Barry AL; Aldridge KE; Gerlach EH
Diagn Microbiol Infect Dis; 1987 Nov; 8(3):157-63. PubMed ID: 3501976
[TBL] [Abstract][Full Text] [Related]
17. Effect of cefamandole, cefuroxime and cefoxitin on yeast fecal flora of surgical patients.
Thomakos N; Maraki S; Liakakos T; Macheras A; Kanavaki S; Marinis E; Sehas M; Margioris AN; Samonis G
Chemotherapy; 1998; 44(5):324-7. PubMed ID: 9732147
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
Werner H; Heizmann W; Luft G
Arzneimittelforschung; 1988 Nov; 38(11):1553-6. PubMed ID: 3214438
[TBL] [Abstract][Full Text] [Related]
19. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.
Knothe H; Shah P; Krcmery V; Antal M; Mitsuhashi S
Infection; 1983; 11(6):315-7. PubMed ID: 6321357
[TBL] [Abstract][Full Text] [Related]
20. [Activity of new cephalosporins against polyresistant bacterial strains].
De Toffoli A; Fantin B
Minerva Med; 1983 Mar; 74(9-10):427-31. PubMed ID: 6300736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
